Stockreport

UPDATE 1-Belgium's UCB to buy Ra Pharmaceuticals in $2.1 bln cash deal [Reuters]

RA PHARMACEUTICALS  (RARX) 
Last ra pharmaceuticals earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rapharma.com/news-investors
PDF Belgium's UCB to buy Ra Pharmaceuticals in $2.1 billion cash deal - Reuters 2 Min Read (Reuters) - UCB has agreed to acquire U.S.-based Ra Pharmaceuticals for $2.1 billi [Read more]